AbbVie dumps unwanted Sosei neuro pact from Allergan's past

Sosei has become the latest victim of AbbVie’s post-Allergan merger clear-out as the new suitor has decided to dump its former partner.

The original deal goes back nearly five years, when then-independent Allergan penned a pact with U.K.- and Japan-based Sosei, and it also came about after a near buyout from Pfizer.